AustraliaHealth

Radiopharm Theranostics (ASX:RAD) secured $12.5 million in fresh capital through an institutional raising.

EBR Systems (ASX:EBR) released a statement addressing online speculation after two patients implanted with its WiSE system.

Resonance Health (ASX:RHT) generated $14.3 million in cash receipts for FY26 while maintaining positive operating cash flow each quarter.

Little Green Pharma (ASX:LGP) CFO Paula Butler has tendered her resignation, effective July 31.

Austco Healthcare (ASX:AHC) secured a $4.2 million maintenance contract for the Jurong Health Complex in Singapore.

Alcidion Group (ASX:ALC) reported a record positive operating cash flow of $24.6 million in cash receipts.

Clinuvel Pharmaceuticals (ASX:CUV) will relocate its corporate headquarters to the U.S. by Jan. 1, 2027 and reduce its global workforce by 10% to 20%.

Dimerix (ASX:DXB) secured a United States patent for its drug candidate DMX-652 through 2043.

Medical technology company PolyNovo (ASX:PNV) reported a 16.1% rise in annual group revenue to $150 million for FY26.

Radiopharm Theranostics (ASX:RAD) reported positive Phase 2b trial results for RAD 101, showing 93% image concordance in brain metastasis patients.

Lumos Diagnostics (ASX:LDX) secured a FebriDx rollout across 30 US urgent care sites handling 200,000 annual patient visits.

Pharmaceutical manufacturer IDT Australia (ASX:IDT) upgraded its financial year 2026 revenue guidance to $16.8 million.